Id: CBI_2296 | Pages: 268 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
Breast Imaging Market size is growing with a CAGR of 8.7% during the forecast period (2025-2032), and the market is projected to be valued at USD 10,169.45 Million by 2032 from USD 5,222.03 Million in 2024. Additionally, the market value for the 2025 attributes to USD 5,659.55 Million.
Breast imaging is the use of different technologies to create pictures of breasts. These pictures are used to detect breast diseases. The primary disease includes breast cancer. This imaging is carried out with two different types. It includes ionizing and non-ionizing. Ionizing technology includes methods such as mammography, tomography, and others. These methods provide detailed images. However, they involve human exposure to radiation. Non-ionizing imaging does not use radiation. It includes methods such as ultrasound, MRI, and others. These methods are safer but do not detect all breast issues. The imaging is used for screening, diagnosis, and treatment. Screening is helpful in detecting cancer and other diseases early. Diagnosis confirms the presence of diseases. Treatment monitoring checks if therapy is working or not.
Breast cancer is a disease where cells in the breast grow in an abnormal way. These abnormal cells form a tumor. Breast imaging help doctors in detecting these cancerous cells early. They use technologies such as mammograms, ultrasound, MRI, and others. Imaging also help doctors in checking if treatment is working properly or not. Globally, more people are facing lifestyle changes. Unhealthy diets, less physical activity, and genetic factors are leading to an increase in breast cancer cases.
For instance,
Overall, the rising incidences of breast cancer is significantly boosting the breast imaging market expansion.
The rate of breast cancers and other diseases are increasing. This is leading to increased number of deaths in women worldwide. Governments are working to improve nations healthcare conditions. They are initiating screening programs to detect breast cancer and other diseases early. They are providing low-cost imaging tests for women. They are also framing new guidelines for medical professionals and hospitals.
For instance,
Thus, supportive government screening programs and guidelines are accelerating the global breast imaging market growth.
There are strict regulations for breast imaging devices manufacturers. These regulations are developed by different regulatory bodies. It includes FDA, EMA, ANVISA, and others. These regulations are made to check that machines are safe for use. They also keep a check for the quality of material used in it. It also evaluates that machines do not contain any harmful substances. All these requirements take a long time to get machine approval. Also, before approval manufacturers are conducting studies to prove their machines are working well. This increases the cost of development. Moreover, each country has different regulatory bodies. They have their own regulations. This creates hurdles for manufacturers who seek to commercialize internationally. Hence, the stringent regulations are hampering the breast imaging market demand.
Imaging technologies are becoming better. Manufacturers are developing machines with improved accuracy. Contrast-enhanced mammography is one example of new technology. It has the capability to detect invasive lobular carcinoma, which are considered as hard to find cancers. Proton magnetic resonance spectroscopy is another emerging technology. It helps in detailed diagnosis without radiation use. Moreover, digital breast tomosynthesis (DBT) is also changing the landscape of the market.
For instance,
Overall, technological advancements are expected to increase breast imaging market opportunities.
Based on technology, the market is categorized into ionizing and non-ionizing.
Trends in Technology:
The ionizing segment accounted for the largest market share in 2024.
The non-ionizing segment is expected to grow at the fastest CAGR over the forecast period.
Based on product type, the market is categorized into medical devices, software & services, and accessories.
Trends in Product Type:
The medical devices segment accounted for the largest market share in 2024.
The software & services segment is expected to grow at the fastest CAGR over the forecast period.
Based on end-use, the market is categorized into hospitals & clinics, diagnostic centers, breast care centers, and others.
Trends in the End-Use:
The hospitals & clinics segment accounted for the largest market share of 57.66% in 2024.
The diagnostic centers segment is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest breast imaging market share at 39.92% and was valued at USD 2,084.63 Million and is expected to reach USD 3,753.96 Million in 2032. In North America, the U.S. accounted for the breast imaging market share of 72.86% during the base year of 2024. The region is facing an aging population, lifestyle changes, and unhealthy diets are leading to an increase in breast cancer cases. This has required continuous breast screening, driving market in the region. Moreover, there are technological advancements observed in the region. 3D mammography and contrast-enhanced mammography (CEM) are improving diagnosis. Hospitals, clinics, and centers in the region are also adopting these newer technologies.
For instance,
Overall, rising breast cancer cases, and technological advancements are driving the market demand in the region.
In Asia Pacific, the breast imaging market is experiencing the fastest growth with a CAGR of 10.7% over the forecast period. Countries such as China, India, Japan, and South Korea are building more hospitals and diagnostic centers. Governments are investing in better medical equipment and digital health. This is driving the market in the region. Many rural areas are now having access to breast screening services. This is due to mobile screening units and new healthcare policies. Moreover, many APAC countries are running awareness programs to educate women about breast cancer. Governments, NGOs, and healthcare providers are promoting mammograms and self-examinations.
Europe's breast imaging market analysis states that several trends are responsible for the progress of the market in the region. European countries are developing strong guidelines for breast cancer screening. Organizations such as the European Commission and national health agencies are recommending regular mammograms for women over 40. This is driving the market. Some countries, such as Sweden and Germany are offering low-cost mammograms. Moreover, many new breasts care centers are opening across Europe. Countries such as France, the UK, and Italy are building modern diagnostic centers. They are installing advanced mammography, ultrasound, and MRI machines. This is further supporting the market growth.
The Middle East and Africa (MEA) breast imaging market analysis states that the region is also witnessing several trends for notable surge. Healthcare industry spending in MEA is increasing. It is especially for countries such as Saudi Arabia, UAE, and South Africa. Governments are investing more money in hospitals, medical equipment, and cancer treatment. Many countries are purchasing modern breast screening machines. This includes 3D mammography and MRI to improve cancer detection. Private hospitals are also expanding their technology. This is driving the market. Moreover, governments and health organizations in MEA are launching awareness campaigns. This is to educate women about importance of breast screening.
Latin America's breast imaging market size is also emerging. Telehealth is growing fast in Latin America, especially in countries such as Brazil, Mexico, and Argentina. Many women in rural areas do not have access to breast cancer screening. Now, telehealth services is allowing for remote consultations with doctors. Patients are sending their breast screening scans online. Specialists analyze them without the need for travel. This is driving the market. Moreover, many hospitals, governments, and private companies in Latin America are working together to improve breast cancer screening. International organizations are partnering with local healthcare to bring AI-powered imaging software to improve diagnosis.
The Breast Imaging market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global Breast Imaging market. Key players in The Breast Imaging industry include-
Product Launch:
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 10,169.45 Million |
CAGR (2025-2032) | 8.7% |
By Technology |
|
By Product Type |
|
By End-Use |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the Breast Imaging market is USD 5,222.03 Million.
Asia Pacific is the fastest-growing region in the Breast Imaging market.
Technology, Product Type, and End-Use segmentation details are covered in the Breast Imaging market
GE Healthcare (U.S.), Hologic, Inc. (U.S.), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan) are some major players in the market.